Insider Selling: Danaher Co. (NYSE:DHR) EVP Sells 22,433 Shares of Stock

Danaher Co. (NYSE:DHR) EVP Joakim Weidemanis sold 22,433 shares of Danaher stock in a transaction that occurred on Thursday, April 25th. The shares were sold at an average price of $250.46, for a total transaction of $5,618,569.18. Following the completion of the sale, the executive vice president now owns 90,412 shares in the company, valued at $22,644,589.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Danaher Trading Up 0.3 %

DHR traded up $0.65 during trading on Friday, reaching $246.45. 2,710,445 shares of the stock traded hands, compared to its average volume of 2,785,746. The company has a quick ratio of 1.37, a current ratio of 1.85 and a debt-to-equity ratio of 0.31. The stock’s 50-day moving average is $248.94 and its 200 day moving average is $230.88. Danaher Co. has a 12 month low of $182.09 and a 12 month high of $259.00. The stock has a market capitalization of $182.54 billion, a PE ratio of 41.66, a P/E/G ratio of 4.19 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, beating the consensus estimate of $1.72 by $0.20. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The firm’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.36 EPS. Equities analysts anticipate that Danaher Co. will post 7.64 earnings per share for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date of this dividend is Wednesday, March 27th. This is an increase from Danaher’s previous quarterly dividend of $0.24. Danaher’s payout ratio is presently 18.31%.

Institutional Investors Weigh In On Danaher

A number of large investors have recently bought and sold shares of DHR. Renaissance Group LLC boosted its position in shares of Danaher by 3.1% during the 1st quarter. Renaissance Group LLC now owns 128,646 shares of the conglomerate’s stock worth $32,126,000 after purchasing an additional 3,885 shares in the last quarter. First National Trust Co boosted its holdings in Danaher by 1.3% in the first quarter. First National Trust Co now owns 36,780 shares of the conglomerate’s stock worth $9,185,000 after acquiring an additional 488 shares in the last quarter. SYSTM Wealth Solutions LLC grew its stake in Danaher by 16.0% in the first quarter. SYSTM Wealth Solutions LLC now owns 13,748 shares of the conglomerate’s stock valued at $3,435,000 after acquiring an additional 1,899 shares during the period. Mesirow Financial Investment Management Inc. acquired a new position in shares of Danaher during the first quarter worth approximately $3,770,000. Finally, MONECO Advisors LLC lifted its holdings in shares of Danaher by 20.7% in the 1st quarter. MONECO Advisors LLC now owns 1,190 shares of the conglomerate’s stock worth $297,000 after purchasing an additional 204 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have issued reports on DHR. KeyCorp lifted their price target on shares of Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a research note on Thursday, February 1st. HSBC raised Danaher from a “hold” rating to a “buy” rating and lifted their target price for the company from $250.00 to $280.00 in a research report on Wednesday, April 17th. Citigroup increased their price target on Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research report on Wednesday. TD Cowen boosted their price target on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Barclays raised their target price on shares of Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a research note on Wednesday. Six analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $270.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.